Keywords: Stroke, CEST & MT, GlutamateThis study investigated the feasibility of GluCEST at 3.0 T for detecting the change of glutamate in the human brain after stroke. The imaging capability of glutamate is validated on the phantom and human brain, respectively. Glutamate at physiological concentrations could be detected by in vitro MRI. The findings of an in vivo investigation revealed that the GluCEST signal of stroke patients differs from that of healthy individuals and that this difference may be detected by 3.0 T MRI. This work provides fresh insights into the use of endogenous glutamate MRI imaging.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords